1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Washington >
  6. Bioleum Acquires Hexas

M&A Deal Summary

Bioleum Acquires Hexas

On December 8, 2025, Bioleum acquired life science company Hexas for 7M USD

Acquisition Highlights
  • This is Bioleum’s 1st transaction in the Life Science sector.
  • This is Bioleum’s largest (disclosed) transaction.
  • This is Bioleum’s 1st transaction in the United States.
  • This is Bioleum’s 1st transaction in Washington.

M&A Deal Summary
Date 2025-12-08
Target Hexas
Sector Life Science
Buyer(s) Bioleum
Deal Type Add-on Acquisition
Deal Value 7M USD

Target

Hexas

Olympia, Washington, United States
Hexas is a biomaterials company that develops regenerative, plant-based raw materials as alternatives to wood, food-crop-derived fuels, and fossil fuel–based feedstocks. The Company grows a proprietary perennial grass (branded XanoGrass) and processes it into a fiber product (XanoFiber) that can be used across industries, including packaging, textiles, composites, energy, and biochemicals, without requiring changes to existing manufacturing systems. Hexas was founded in 2018 and is based in Olympia, Washington.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bioleum

Oklahoma City, Oklahoma, United States
Category Company
Sector Business Services
DESCRIPTION

Bioleum is an energy technology firm focused on converting lignocellulosic biomass, such as wood waste, agricultural residues, forestry thinnings, or purpose-grown energy crops, into low-carbon fuels and renewable chemical feedstocks. The company's platform fractionates biomass into its building blocks (cellulose, hemicellulose, lignin), producing products such as cellulosic ethanol, renewable diesel/gasoline, sustainable aviation fuel (SAF), bio-intermediates, and specialty chemical feedstocks. Bioleum is headquartered in Oklahoma City, Oklahoma.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Washington M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Size (of disclosed) 1 of 1
Mergr

Solution for

Product

Company

Legal